Forum Replies Created

  • Jennifer

    Member
    October 22, 2021 at 10:03 am in reply to: N115 nasal spray

    I am wondering if Emphycorp could or would request fast track designation by the FDA?

  • Jennifer

    Member
    October 17, 2021 at 6:29 pm in reply to: N115 nasal spray

    Hello, when we asked my Dad’s doctor about this he said that phase three medicines are not available for prescription. Has anyone else asked their pulmonologist last?
    On Emphycorp website:

    ”t<span lang=”EN-GB”>he Clinical trials with our nasal spray demonstrated a statistically and clinically significant increase FEV-1, SaO2, FVC, FEV-1/FVC ratios (52% to 86%),and  nitric oxide, (needed to increase bronchial dilation and fight infections), and a significant reduction of coughing, nasal erythema and inflammation and congestion, in all patients tested with Idiopathic pulmonary fibrosis.  </span>In all  patients, the test results were compared to their previous three-week screening and baseline data (there current therapies) as the placebo control for each variable including all their lung functions, FEV-1, FVC, PEF, FEV-1/FVC ratios, SaO2, Nitric oxide, coughing rates, nasal inflammation. ”

    https://www.emphycorp.com/pulmonary-fibrosis-treatment

     

    • Jennifer

      Member
      October 18, 2021 at 7:15 am in reply to: N115 nasal spray

      I meant to say has anyone asked their pulmonologist about this?